Qiming-backed biotech firm AusperBio raises $73m in Series B round
Chinese biotech firm AusperBio, backed by the likes of Qiming Venture Partners, has raised $73 million in fresh capital to expand its pipeline and operations. The Series B round was led by healthcare-focused investment firm HanKang Capital. The round was …